ONL Therapeutics
Ann Arbor, MI
ONL Therapeutics, Inc. operates as a biopharmaceutical company. The Company develops drugs for the treatment of serious, vision-threatening retinal diseases, and conditions including retinal detachment and wet and dry forms of age-related macular degeneration. ONL Therapeutics serves patients in the United States.
onltherapeutics.comCompany Details
Founded
- 2014
Employees
- Between 20 - 50 employees
Raised
- $82,937,920
Headquarters Location
- Ann Arbor, MI
Public
- No
Acquired
- No
CEO
David Esposito
Founders
- David Zacks
Company Collections
These are collections ONL Therapeutics is a part of. Click on the collection name to view similar companies.